Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€27.40
Target price
20.11.24
€32.04
Performance (%)
65.69%
Price
07.08.24
€44.20
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc has seen massive gains of 65.69%. This prediction currently runs until 20.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | -3.913% | -3.913% |
iShares Core DAX® | 2.722% | -4.863% |
iShares Nasdaq 100 | 4.546% | -7.240% |
iShares Nikkei 225® | 6.353% | -6.674% |
iShares S&P 500 | 3.194% | -3.832% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $35.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.60
09.07.24
09.07.24
€49.94
09.07.25
09.07.25
-0.90%
07.08.24
07.08.24